The host-cell architectural protein HMG I(Y) modulates binding of herpes simplex virus type 1 ICP4 to its cognate promoter

Virology

Volumn 256, Issue 1, 1999, Pages 64-74

  Panagiotidis, Christos A ^a   Silverstein, Saul J ^a  

^a New York Presbyterian Columbia University Medical Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENTARY DNA; GENE PRODUCT; HIGH MOBILITY GROUP PROTEIN;

ARTICLE; BINDING SITE; CONTROLLED STUDY; DNA LIBRARY; HELA CELL; HERPES SIMPLEX VIRUS 1; HOST CELL; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION;

EID: 0033616532     PISSN: 00426822     EISSN: None     Source Type: Journal    
DOI: 10.1006/viro.1999.9607     Document Type: Article

References (89)

1. Bellorini M., Moncollin V., D'Incalci M., Mongelli N., Mantovani R. Distamycin A and tallimustine inhibit TBP binding and basalin vitro. Nucleic Acids Res. 23:1995;1657-1663.
2. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
3. Brasier A. R., Tate J. E., Habener J. F. Optimized use of the firefly luciferase assay as a reporter gene in mammalian cell lines. BioTechniques. 7:1989;1116-1122.
4. Bustin M., Reeves R. High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function. Prog. Nucleic Acids Res. Mol. Biol. 54:1996;35-100.
5. Carey M. The enhanceosome and transcriptional synergy. Cell. 92:1998;5-8.
6. Carrozza M. J., DeLuca N. A. Interaction of the viral activator protein ICP4 with TFIID through TAF250. Mol. Cell. Biol. 16:1996;3805-3093.
7. Carrozza M. J., DeLuca N. A. The high mobility group protein 1 is a coactivator of herpes simplex virus ICP4 in vitro. J. Virol. 76:1998;6752-6757.
8. DeLuca N. A., McCarthy A. M., Schaffer P. A. Isolation and characterization of deletion mutants of herpes simplex virus type 1 in the gene encoding immediate early regulatory protein ICP4. J. Virol. 56:1985;558-570.
9. DiDonato J. A., Spitzner J. R., Muller M. T. A predictive model for DNA recognition by the herpes simplex virus protein ICP4. J. Mol. Biol. 219:1991;451-470.
10. Dignam J. D., Lebowitz R. M., Roeder R. G. Accurate transcription initiation by RNA polymerase II in a soluble extract from isolated mammalian nuclei. Nucleic Acids Res. 11:1983;1475-1489.
11. Dixon R. F., Schaffer P. A. Fine structure mapping and functional analysis of temperature-sensitive mutants in the gene encoding the herpes simplex virus type 1 immediate early protein VP175. J. Virol. 36:1980;189-203.
12. Eckner R., Birnstiel M. L. Cloning of cDNAs coding for human HMG I and HMG Y proteins: Both are capable of binding to the octamer sequence motif. Nucleic Acids Res. 17:1989;5947-5959.
13. Everett R. D. Trans activation of transcription by herpes virus products: Requirement for two HSV-1 immediate-early polypeptides for maximum activity. EMBO J. 3:1984;3135-3141.
14. Everett R. D. The products of herpes simplex virus type 1 (HSV-1) immediate early genes 1, 2, and 3 can activate HSV-1 gene expression in trans. J. Gen. Virol. 68:1986;2507-2513.
15. Everett R. D., Elliott M., Hope G., Orr A. Purification of the DNA binding domain of herpes simplex virus type 1 immediate-early protein Vmw175 as a homodimer and extensive mutagenesis of its recognition site. Nucleic Acids Res. 19:1991;4901-4908.
16. Faber S. W., Wilcox K. W. Association of the herpes simplex virus regulatory protein ICP4 with specific nucleotide sequences in DNA. Nucleic Acids Res. 14:1986;6067-6083.
17. Falvo J. V., Thanos D., Maniatis T. Reversal of intrinsic DNA bends in the IFNβ gene enhancer by transcription factors and the architectural protein HMG I(Y). Cell. 83:1995;1101-1111.
18. Fashena S. J., Reeves R., Ruddle N. H. A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor) gene regulation. Mol. Cell. Biol. 12:1992;894-903.
19. French S. W., Schmidt M. C., Glorioso J. C. Involvement of a high-mobility-group protein in the transcriptional activity of herpes simplex virus latency-active promoter 2. Mol. Cell. Biol. 16:1996;5393-5399.
20. Gelman I. H., Silverstein S. Identification of immediate early genes from herpes simplex virus that transactivate the virus thymidine kinase gene. Proc. Natl. Acad. Sci. USA. 82:1985;5265-5269.
21. Gelman I. H., Silverstein S. Herpes simplex virus immediate-early promoters are responsive to virus and cell trans-acting factors. J. Virol. 61:1987;2286-2296.
22. Ghersa P., Whelan J., Cambet Y., DeLamarter J. F., Hooft van Huijsduijnen R. Distamycin prolongs E-selectin expression by interacting with a specific NF-kappaB-HMG-I(Y) binding site in the promoter. Nucleic Acids Res. 25:1997;339-346.
23. Gu B., DeLuca N. Requirements for activation of the herpes simplex virus glycoprotein C promoter in vitro by the viral regulatory protein ICP4. J. Virol. 68:1994;7953-7965.
24. Gu B., Kuddus R., DeLuca N. Repression of activator-mediated transcription by herpes simplex virus via a mechanism involving interactions with the basal transcription factors TATA-binding protein and TFIIB. Mol. Cell. Biol. 15:1995;3618-3626.
25. Hardwicke M. A., Vaughan P. J., Sekulovich R. E., O'Conner R., Sandri-Goldin R. M. The regions important for the activator and repressor functions of herpes simplex virus type 1α protein ICP27 map to the C-terminal half of the molecule. J. Virol. 63:1989;4590-4602.
26. Hardy W. R., Sandri-Goldin R. M. Herpes simplex virus inhibits host cell splicing, and regulatory protein ICP27 is required for this effect. J. Virol. 68:1994;7790-7799.
27. Hill A., Jugovic P., York I., Russ G., Bennink J., Yewdell J., Ploegh H., Johnson D. Herpes simplex virus turns off the TAP to evade host immunity. Nature. 375:1995;411-415.
28. Honess R. W., Roizman B. Regulation of herpesvirus macro-molecular synthesis. I. Cascade regulation of the synthesis of three groups of viral proteins. J. Virol. 14:1974;8-19.
29. Honess R. W., Roizman B. Regulation of herpesvirus macro-molecular synthesis: Sequential transition of polypeptide synthesis requires functional viral polypeptides. Proc. Natl. Acad. Sci. USA. 72:1975;1276-1280.
30. Johnson K. R., Lehn D. A., Elton T. S., Barr P. J., Reeves R. Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG I(Y). J. Biol. Chem. 263:1988;18338-18342.
31. Johnson K. R., Lehn D. A., Reeves R. Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y. Mol. Cell. Biol. 9:1989;2114-2123.
32. Jordan R., Schaffer P. Activation of gene expression by herpes simplex virus type 1 ICP0 occurs at the level of mRNA synthesis. J. Virol. 71:1997;6850-6862.
33. Knipe D. M., Ruyechan W. T., Roizman B., Halliburton I. A. Molecular genetics of herpes simplex virus: Demonstration of regions of obligatory and nonobligatory identity within diploid regions of the genome by sequence replacement and insertion. Proc. Natl. Acad. Sci. USA. 75:1978;3896-3900.
34. Laemmli U. K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature. 227:1970;680-685.
35. Lehming N., Thanos D., Brickman J. M., Ma J., Maniatis T., Ptashne M. An HMG-like protein that can switch a transcriptional activator to a repressor. Nature. 371:1994;175-179.
36. Lium E. K., Panagiotidis C. A., Wen X., Silverstein S. J. Repression of the α0 gene by ICP4 during a productive herpes simplex virus infection. J. Virol. 70:1996;3488-3496.
37. Maher J. F., Nathans D. Multivalent DNA-binding properties of the HMG-I proteins. Proc. Natl. Acad. Sci. USA. 93:1996;6716-6720.
38. McCarthy A. M., McMahan L., Schaffer P. A. Herpes simplex virus type 1 ICP27 deletion mutants exhibit altered patterns of transcription and are DNA deficient. J. Virol. 63:1989;18-27.
39. McGregor F., Phelan A., Dunlop J., Clements J. B. Regulation of herpes simplex virus poly(A) site usage and the action of immediate-early protein IE63 in the early-late switch. J. Virol. 70:1996;1931-1940.
40. McLauchlan J., Phelan A., Loney C., Sandri-Goldin R. M., Clements J. B. Herpes simplex virus IE63 acts at the posttranscriptional level to stimulate viral mRNA 3′ processing. J. Virol. 66:1992;6939-6945.
41. McLauchlan J., Simpson S., Clements J. B. Herpes simplex virus induces a processing factor that stimulates poly(A) site usage. Cell. 59:1989;1093-1105.
42. McMahan L., Schaffer P. A. Repressing and enhancing functions of the herpes simplex virus regulatory protein ICP27 map to C-terminal regions and are required to modulate viral gene expression very early in infection. J. Virol. 64:1990;3471-3485.
43. Michael N., Roizman B. Binding of the herpes simplex virus major regulatory protein to viral DNA. Proc. Natl. Acad. Sci. USA. 86:1989;9808-9812.
44. Michael N., Spector D., Mavromara-Nazos P., Kristie T. M., Roizman B. The DNA-binding properties of the major regulatory protein α4 of herpes simplex viruses. Science. 239:1988;1531-1534.
45. Mote J., Ghanouni P., Reines D. A DNA minor groove-binding ligand both potentiates and arrests transcription by RNA polymerase II. J. Mol. Biol. 236:1994;725-737.
46. Mullen M. A., Gerstberger S., Ciufo D. M., Mosca J. D., Hayward G. S. Evaluation of colocalization interactions between the IE110, IE175, and IE63 transactivator proteins of herpes simplex virus within subcellular punctate structures. J. Virol. 69:1995;476-491.
47. O'Hare P., Hayward G. S. Evidence for a direct role for both the 175000 and 110000 molecular-weight immediate early proteins of herpes simplex virus in the transactivation of delayed-early promoters. J. Virol. 53:1985a;751-760.
48. O'Hare P., Hayward G. S. Three trans-acting regulatory proteins of herpes simplex virus modulate immediate-early gene expression in a pathway involving positive and negative feedback regulation. J. Virol. 56:1985b;723-733.
49. Ogawa Y., Aizawa S., Shirakawa H., Yoshida M. Stimulation of transcription accompanying relaxation of chromatin structure in cells overexpressing high mobility group 1 protein. J. Biol. Chem. 270:1995;9272-9280.
50. Panagiotidis C. A., Artandi S., Calame K., Silverstein S. J. Polyamines alter sequence-specific DNA-protein interactions. Nucleic Acids Res. 23:1995;1800-1809.
51. Panagiotidis C. A., Lium E. K., Silverstein S. J. Physical and functional interactions between herpes simplex virus immediate early proteins ICP4 and ICP27. J. Virol. 71:1997;1547-1557.
52. Papavassiliou A. G., Silverstein S. J. Characterization of DNA-protein complex formation in nuclear extracts with a sequence from the herpes simplex virus thymidine kinase gene. J. Biol. Chem. 265:1990a;1648-1657.
53. Papavassiliou A. G., Silverstein S. J. Interaction of cell and virus proteins with DNA sequences encompassing the promoter/regulatory and leader regions of the herpes simplex virus thymidine kinase gene. J. Biol. Chem. 265:1990b;9402-9412.
54. Papavassiliou A. G., Wilcox K. W., Silverstein S. J. The interaction of ICP4 with cell/infected factors and its state of phosphorylation modulate differential recognition of leader sequences in herpes simplex virus DNA. EMBO J. 10:1991;397-406.
55. Phelan A., Carmo-Fonseca M., McLauchlan J., Lamond A. I., Clements J. B. A herpes simplex virus type 1 immediate-early gene product, IE63, regulates small nuclear ribonucleoprotein distribution. Proc. Natl. Acad. Sci. USA. 90:1993;9056-9060.
56. Preston C. M. Control of herpes simplex virus type 1 mRNA synthesis in cells infected with wild-type virus or the temperature-sensitive mutant tsK. J. Virol. 29:1979;275-284.
57. Quinlan M. P., Knipe D. Stimulation of expression of a herpes simplex virus DNA-binding protein by two viral factors. Mol. Cell. Biol. 5:1985;957-963.
58. Reeves R., Nissen M. S. The A-T-DNA-binding domain of mammalian high mobility group I chromosomal proteins. J. Biol. Chem. 265:1990;8573-8582.
59. Rice S. A., Knipe D. M. Gene-specifictrans. J. Virol. 62:1988;3814-3823.
60. Rice S. A., Knipe D. M. Genetic evidence for two distinct trans-activation functions of the herpes simplex virus α protein ICP27. J. Virol. 64:1990;1704-1715.
61. Rice S. A., Long M. C., Lam V., Schaffer P. A., Spencer C. A. Herpes simplex virus immediate-early protein ICP22 is required for viral modification of host RNA polymerase II and establishment of the normal viral transcription program. J. Virol. 69:1995;5550-5559.
62. Roberts M. S., Boundy A., O'Hare P., Pizzorno M. C., Ciufo D. M., Hayward G. S. Direct correlation between a negative autoregulatory response element at the cap site of the herpes simplex virus type 1 IE175 (α4) promoter and a specific binding site for the IE175 (ICP4) protein. J. Virol. 62:1988;4307-4320.
63. Roizman B., Sears A. Herpes simplex viruses and their replication. Fields Virology, 1996;Lippincott-Raven Publishers, Philadelphia. p. 2231-2295.
64. Sacks W. R., Greene C. C., Aschman D. P., Schaffer P. A. Herpes simplex virus type 1 ICP27 is an essential regulatory protein. J. Virol. 55:1985;796-805.
65. Samaniego L. A., Webb A. L., DeLuca N. A. Functional interactions between herpes simplex virus immediate-early proteins during infection: Gene expression as a consequence of ICP27 and different domains of ICP4. J. Virol. 69:1995;5705-5715.
66. Sandri-Goldin R. M. ICP27 mediates HSV RNA export by shuttling through a leucine-rich nuclear export signal and binding viral intronless RNAs through an RGG motif. Genes Dev. 12:1998;868-879.
67. Sandri-Goldin R. M., Mendoza G. E. A herpesvirus regulatory protein appears to act post-transcriptionally by affecting mRNA processing. Genes Dev. 6:1992;848-863.
68. Sekulovich R. E., Leary K., Sandri-Goldin R. M. The herpes simplex virus type 1 α protein ICP27 can act as atranstrans. J. Virol. 62:1988;4510-4522.
69. Shepard A. A., Imbalzano A. N., DeLuca N. A. Separation of primary structural components conferring autoregulation, transactivation, and DNA-binding properties to the herpes simplex virus transcriptional regulatory protein ICP4. J. Virol. 63:1989;3714-3728.
70. Showalter S. D., Zweig M., Hampar B. Monoclonal antibodies to herpes simplex virus type 1 proteins, including the immediate-early protein ICP4. Infect. Immunol. 34:1981;684-692.
71. Singh H., LeBowitz J. H., Baldwin J. A. S., Sharp P. A. Molecular cloning of an enhancer binding protein: Isolation by screening of an expression library with a recognition site DNA. Cell. 52:1988;415-423.
72. Smith C. A., Bates P., Rivera-Gonzalez R., Gu B., DeLuca N. A. ICP4, the major transcriptional regulatory protein of herpes simplex virus type 1, forms a tripartite complex with TATA-binding protein and TFIIB. J. Virol. 67:1993;4676-4687.
73. Smith D. B., Johnson K. S. Single-step purification of polypeptides expressed inEscherichia coli. Gene. 67:1988;31-40.
74. Soliman T., Sandri-Goldin R., Silverstein S. Shuttling of the herpes simplex virus type 1 regulatory protein ICP27 between the nucleus and cytoplasm mediates the expression of late proteins. J. Virol. 71:1997;9188-9197.
75. Solomon M. J., Strauss F., Varshavsky A. A mammalian high mobility group protein recognizes any stretch of six A-T base pairs in duplex DNA. Proc. Natl. Acad. Sci. USA. 83:1984;1276-1280.
76. Su L., Knipe D. M. Herpes simplex virus α protein ICP27 can inhibit or augment viral gene transactivation. Virology. 170:1989;496-504.
77. Tabor C. W., Tabor H. Polyamines. Annu. Rev. Biochem. 53:1984;749-790.
78. Thanos D., Maniatis T. The high mobility group protein HMG I(Y) is required for NF-κB-dependent virus induction of the human IFN-β gene. Cell. 71:1992;777-789.
79. Thanos D., Maniatis T. Virus induction of human IFNβ gene expression requires the assembly of an enhanceosome. Cell. 83:1995;1091-1100.
80. van Zonneveld A. J., Curriden S. A., Loskutoff D. J. Type 1 plasminogen activator inhibitor gene: Functional analysis and glucocorticoid regulation of its promoter. Proc. Natl. Acad. Sci. USA. 85:1988;5525-5529.
81. Watson R. J., Clements J. B. Characterization of transcription-deficient temperature-sensitive mutants of herpes simplex virus. Virology. 91:1978;364-379.
82. Watson R. J., Clements J. B. A herpes simplex type 1 function continuously required for early and late virus RNA synthesis. Nature. 285:1980;329-330.
83. Wigler M., Pellicer A., Silverstein S., Axel R., Urlaub G., Chasin L. DNA-mediated transfer of the adenine phosphoribosyltransferase locus into mammalian cells. Proc. Natl. Acad. Sci. USA. 76:1979;1373-1376.
84. Wood L. D., Farmer A. A., Richmond A. HMGI(Y) and Sp1 in addition to NF-kappa B regulate transcription of the MGSA/GRO alpha gene. Nucleic Acids Res. 23:1995;4210-4219.
85. Xia K., DeLuca N. A., Knipe D. M. Analysis of phosphorylation sites of herpes simplex virus type 1 ICP4. J. Virol. 70:1996;1061-1071.
86. +. Cell. 77:1994;525-535.
87. Zhou X., Chada K. HMGI family proteins: Architectural transcription factors in mammalian development and cancer. Keio J. Med. 47:1998;73-77.
88. Zhu Z., Cai W., Schaffer P. A. Cooperativity among herpes simplex virus type 1 immediate-early regulatory proteins: ICP4 and ICP27 affect the intracellular localization of ICP0. J. Virol. 68:1994;3027-3040.
89. Zhu Z., Schaffer P. A. Intracellular localization of the herpes simplex virus type 1 major transcriptional regulatory protein, ICP4, is affected by ICP27. J. Virol. 69:1995;49-59.